Position in CGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,504
+$10 QoQ
Shares Held
10,005
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 212 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $12,974,406 across 11 Drug Manufacturers - Specialty & Generic names. CGC ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
351,770 | $5,638,872 | |
| 2 | HLN |
Haleon plc
|
314,017 | $2,929,778 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
16,440 | $1,360,903 | |
| 4 | ALKS |
Alkermes plc.
|
15,829 | $829,439 | |
| 5 | VTRS |
Viatris Inc
|
39,511 | $627,434 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
23,600 | $580,796 | |
| 7 | ZTS |
Zoetis Inc.
|
7,289 | $523,787 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,069 | $307,257 |
All Filings in CGC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,504 | 10,005 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $9,494 | 10,005 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $11,400 | 10,000 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $14,600 | 10,000 | Shares | Other | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||